Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of MenAC-TT Vaccine in Healthy Chinese Children
NCT03714737Phase 3Completed
- Sponsor
- Jiangsu Provincial Center for Disease Control and Prevention
- Start
- May 2016
- Primary completion
- Sep 2017
- Modality
- Split/Subunit Vaccines
01
Overview
A Phase 3 trial of meningococcal group A and C conjugate vaccine in meningococcal disease, sponsored by Jiangsu Provincial Center for Disease Control and Prevention. Started May 2016; status: completed.
02
Drugs
meningococcal group A and C conjugate vaccine
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on NCT03714737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03714737.